A new central scaffold for metastasis: parsing HEF1/Cas-L/NEDD9.
暂无分享,去创建一个
[1] Yili Yang,et al. Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics. , 2007, Cancer research.
[2] M. Boerma,et al. Local administration of interleukin-11 ameliorates intestinal radiation injury in rats. , 2007, Cancer research.
[3] T. Dörk,et al. Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium. , 2007, Cancer research.
[4] U. Şahin,et al. A placenta-specific gene ectopically activated in many human cancers is essentially involved in malignant cell processes. , 2007, Cancer research.
[5] T. Sugimura,et al. SND1, a component of RNA-induced silencing complex, is up-regulated in human colon cancers and implicated in early stage colon carcinogenesis. , 2007, Cancer research.
[6] H. Sontheimer,et al. Autocrine glutamate signaling promotes glioma cell invasion. , 2007, Cancer research.
[7] A. Eggermont,et al. Tumor necrosis factor alpha mediates homogeneous distribution of liposomes in murine melanoma that contributes to a better tumor response. , 2007, Cancer research.
[8] K. Flaherty,et al. Cell cycle dependent and schedule-dependent antitumor effects of sorafenib combined with radiation. , 2007, Cancer research.
[9] Erica A. Golemis,et al. HEF1-Dependent Aurora A Activation Induces Disassembly of the Primary Cilium , 2007, Cell.
[10] G. O'Neill,et al. Molecular basis for HEF1/NEDD9/Cas-L action as a multifunctional co-ordinator of invasion, apoptosis and cell cycle , 2007, Cell Biochemistry and Biophysics.
[11] T. Benzing,et al. Von hippel-lindau: a tumor suppressor links microtubules to ciliogenesis and cancer development. , 2007, Cancer research.
[12] A. Harris,et al. Transcriptional Profiling of Human Cord Blood CD133+ and Cultured Bone Marrow Mesenchymal Stem Cells in Response to Hypoxia , 2007, Stem cells.
[13] K. Mohammad,et al. Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis. , 2007, Cancer research.
[14] S. Iwata,et al. Crk-associated substrate lymphocyte type regulates transforming growth factor-β signaling by inhibiting Smad6 and Smad7 , 2007, Oncogene.
[15] K. Alexandropoulos,et al. The hematopoietic isoform of Cas-Hef1-associated signal transducer regulates chemokine-induced inside-out signaling and T cell trafficking. , 2006, Immunity.
[16] Michael P. Sheetz,et al. Force Sensing by Mechanical Extension of the Src Family Kinase Substrate p130Cas , 2006, Cell.
[17] L. Chin,et al. Comparative Oncogenomics Identifies NEDD9 as a Melanoma Metastasis Gene , 2006, Cell.
[18] E. Golemis,et al. Deregulation of HEF1 impairs M-phase progression by disrupting the RhoA activation cycle. , 2005, Molecular biology of the cell.
[19] H. Okano,et al. Nedd9 Protein, a Cas-L Homologue, Is Upregulated After Transient Global Ischemia in Rats: Possible Involvement of Nedd9 in the Differentiation of Neurons After Ischemia , 2005, Stroke.
[20] Erica A. Golemis,et al. The focal adhesion scaffolding protein HEF1 regulates activation of the Aurora-A and Nek2 kinases at the centrosome , 2005, Nature Cell Biology.
[21] S. Ogawa,et al. Crk-Associated Substrate Lymphocyte Type Is Required for Lymphocyte Trafficking and Marginal Zone B Cell Maintenance1 , 2005, The Journal of Immunology.
[22] Cynthia A. Reinhart-King,et al. Tensional homeostasis and the malignant phenotype. , 2005, Cancer cell.
[23] Andy J. Minn,et al. Genes that mediate breast cancer metastasis to lung , 2005, Nature.
[24] Dennis C. Sgroi,et al. Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.
[25] Jean Paul Thiery,et al. Epithelial-mesenchymal transitions in development and pathologies. , 2003, Current opinion in cell biology.
[26] G. O'Neill,et al. The GDP Exchange Factor AND-34 Is Expressed in B Cells, Associates With HEF1, and Activates Cdc421 , 2003, The Journal of Immunology.
[27] Jonathan Chernoff,et al. Detection of peptides, proteins, and drugs that selectively interact with protein targets. , 2002, Genome research.
[28] P. McKeown-Longo,et al. Regulation of HEF1 Expression and Phosphorylation by TGF-β1 and Cell Adhesion* , 2002, The Journal of Biological Chemistry.
[29] G. O'Neill,et al. Integrin signalling: a new Cas(t) of characters enters the stage. , 2000, Trends in cell biology.
[30] N. Heisterkamp,et al. BCR/ABL-induced Leukemogenesis Causes Phosphorylation of Hef1 and Its Association with Crkl* , 1997, The Journal of Biological Chemistry.
[31] S. Iwata,et al. Structure and function of Cas-L, a 105-kD Crk-associated substrate- related protein that is involved in beta 1 integrin-mediated signaling in lymphocytes , 1996, The Journal of experimental medicine.
[32] E. Golemis,et al. Human enhancer of filamentation 1, a novel p130cas-like docking protein, associates with focal adhesion kinase and induces pseudohyphal growth in Saccharomyces cerevisiae , 1996, Molecular and cellular biology.
[33] S. Kumar,et al. Identification of a set of genes with developmentally down-regulated expression in the mouse brain. , 1992, Biochemical and biophysical research communications.
[34] E. Golemis,et al. HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells , 2007, Oncogene.
[35] M. Kurokawa,et al. Structure and function of cas-L and integrin-mediated signaling. , 2006, Critical reviews in immunology.
[36] M. Einarson,et al. Dissection of HEF1-dependent functions in motility and transcriptional regulation. , 2002, Journal of cell science.